{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T17:07:05Z","timestamp":1765300025567,"version":"3.46.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Geriatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Elderly patients with atrial fibrillation (AF) are at increased risk of death, despite oral anticoagulant (OAC) treatment. We estimated the risk of all cause and cardiovascular (CV) death associated with hospitalizations for cardiovascular events (CVEs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Retrospective cohort study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      OAC treated patients (\u2265\u200975 years) (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20092161) discharged from a Swedish cardiology clinic with AF or atrial flutter (AFL) as main diagnosis between 2010 and 2017, were followed up for 12 months. Hospitalizations for CVEs were recorded from the national patient registry and diagnoses combined in five groups: heart failure (HF); stroke\/ transient ischemic attack (TIA)\/systemic embolism (SE); acute myocardial infarction and peripheral artery disease; bleeding; and other CVEs. We estimated the risk, expressed as hazard ratio (HR) and 95% confidence interval (CI) for all-cause and CV death in each hospitalization group by time-varying Cox regression.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>During 12 months of follow up, 178 patients died and 92 were CV deaths. Overall, 391 (18.5%) patients experienced a total of 490 hospitalizations for CVEs. Hospitalizations for any CVEs associated with increased risk (from 3 to 17 folds) for all-cause mortality. Risk for CV mortality increased in patients hospitalized for HF within 90 days (HR and 95%CI) 33.64 (15.97\u201370.89), for stroke\/TIA\/SE 14.73 (7.60-28.58) and for other CVEs 8.98 (4.29\u201318.78).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Hospitalizations for CVEs in elderly AF\/AFL OAC treated patients increased the risk for all cause and CV mortality within 12 months from admission for AF\/AFL. Hospitalization for HF bared the highest risk, but the residual stroke\/TIA\/SE risk was noteworthy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12877-025-06733-8","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T05:04:05Z","timestamp":1765256645000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hospitalizations for cardiovascular events and risk for all cause and cardiovascular mortality in elderly patients with atrial fibrillation treated with oral anticoagulants: beyond preventing thromboembolism"],"prefix":"10.1186","volume":"25","author":[{"given":"Matteo","family":"Candeloro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiaosen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanne","family":"Ehrlinder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruna","family":"Gigante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,9]]},"reference":[{"issue":"5","key":"6733_CR1","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstr\u00f6m-Lundqvist C, et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European association for cardio-thoracic surgery (EACTS). Eur Heart J. 2021;42(5):373\u2013498.","journal-title":"Eur Heart J"},{"key":"6733_CR2","unstructured":"Van Gelder IC, Rienstra M, Bunting KV, Casado-Arroyo R, Caso V, Crijns H et al. 2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European association for Cardio-Thoracic surgery (EACTS). Eur Heart J. 2024. ;45(36):3314-3414."},{"issue":"10","key":"6733_CR3","first-page":"1332","volume":"35","author":"P Meyre","year":"2019","unstructured":"Meyre P, Blum S, Berger S, Aeschbacher S, Schoepfer H, Briel M, et al. Risk of hospital admissions in patients with atrial fibrillation: a systematic review and meta-analysis. Can J Cardiol. 2019;35(10):1332\u201343.","journal-title":"Can J Cardiol"},{"issue":"24","key":"6733_CR4","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1093\/eurheartj\/ehae204","volume":"45","author":"LTH Ngo","year":"2024","unstructured":"Ngo LTH, Peng Y, Denman R, Yang I, Ranasinghe I. Long-term outcomes after hospitalization for atrial fibrillation or flutter. Eur Heart J. 2024;45(24):2133\u201341.","journal-title":"Eur Heart J"},{"issue":"23","key":"6733_CR5","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1016\/j.jacc.2016.09.944","volume":"68","author":"A Gomez-Outes","year":"2016","unstructured":"Gomez-Outes A, Lagunar-Ruiz J, Terleira-Fernandez AI, Calvo-Rojas G, Suarez-Gea ML, Vargas-Castrillon E. Causes of death in anticoagulated patients with atrial fibrillation. J Am Coll Cardiol. 2016;68(23):2508\u201321.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"6733_CR6","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jacc.2023.08.017","volume":"83","author":"JA Joglar","year":"2024","unstructured":"Joglar JA, Chung MK, Armbruster AL, Benjamin EJ, Chyou JY, Cronin EM, et al. 2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation. J Am Coll Cardiol. 2024;83(1):109\u2013279.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"6733_CR7","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/j.jamda.2023.05.010","volume":"24","author":"X Wang","year":"2023","unstructured":"Wang X, Wang T, Chen X, Tian W, Ma D, Zhang J, et al. Efficacy and safety of oral anticoagulants in older adult patients with atrial fibrillation: pairwise and network Meta-Analyses. J Am Med Dir Assoc. 2023;24(8):1233\u2013e926.","journal-title":"J Am Med Dir Assoc"},{"issue":"12","key":"6733_CR8","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/j.amjmed.2016.06.045","volume":"129","author":"L Fauchier","year":"2016","unstructured":"Fauchier L, Villejoubert O, Clementy N, Bernard A, Pierre B, Angoulvant D, et al. Causes of death and influencing factors in patients with atrial fibrillation. Am J Med. 2016;129(12):1278\u201387.","journal-title":"Am J Med"},{"key":"6733_CR9","doi-asserted-by":"crossref","unstructured":"Noubiap JJ, Tang JJ, Dewland TA, Marcus GM. Contemporary trends in incident ischemic stroke, intracranial hemorrhage, and mortality in individuals with atrial fibrillation. Eur Heart J Qual Care Clin Outcomes. 2024.","DOI":"10.1161\/circ.149.suppl_1.MP24"},{"issue":"1","key":"6733_CR10","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1007\/s11357-023-00825-2","volume":"46","author":"K Doni","year":"2024","unstructured":"Doni K, Buhn S, Weise A, Mann NK, Hess S, Sonnichsen A, et al. Safety outcomes of direct oral anticoagulants in older adults with atrial fibrillation: a systematic review and meta-analysis of (subgroup analyses from) randomized controlled trials. Geroscience. 2024;46(1):923\u201344.","journal-title":"Geroscience"},{"key":"6733_CR11","unstructured":"WHO, Ageing. and Health 2022 [Available from: https:\/\/www"},{"issue":"35","key":"6733_CR12","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1093\/eurheartj\/eht280","volume":"34","author":"BP Krijthe","year":"2013","unstructured":"Krijthe BP, Kunst A, Benjamin EJ, Lip GY, Franco OH, Hofman A, et al. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur Heart J. 2013;34(35):2746\u201351.","journal-title":"Eur Heart J"},{"issue":"4","key":"6733_CR13","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1093\/europace\/euac123","volume":"25","author":"I Savelieva","year":"2023","unstructured":"Savelieva I, Fumagalli S, Kenny RA, Anker S, Benetos A, Boriani G, et al. EHRA expert consensus document on the management of arrhythmias in frailty syndrome, endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA). Europace. 2023;25(4):1249\u201376.","journal-title":"Europace"},{"issue":"16","key":"6733_CR14","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003484","volume":"95","author":"KP Lin","year":"2016","unstructured":"Lin KP, Chen PC, Huang LY, Mao HC, Chan DD. Predicting inpatient readmission and outpatient admission in elderly: a population-based cohort study. Med Baltim. 2016;95(16):e3484.","journal-title":"Med Baltim"},{"issue":"5","key":"6733_CR15","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.hroo.2022.06.002","volume":"3","author":"C Weber","year":"2022","unstructured":"Weber C, Hung J, Hickling S, Li I, Murray K, Briffa T. Unplanned 30-day readmission, comorbidity, and impact on mortality after incident atrial fibrillation hospitalization in Western Australia, 2001\u20132015. Heart Rhythm O2. 2022;3(5):511\u20139.","journal-title":"Heart Rhythm O2"},{"issue":"8","key":"6733_CR16","doi-asserted-by":"publisher","first-page":"101117","DOI":"10.1016\/j.jacadv.2024.101117","volume":"3","author":"D Menichelli","year":"2024","unstructured":"Menichelli D, Pignatelli P, Brogi T, Pannunzio A, Violi F, Lip GYH, et al. Incidence of All-Cause, Cardiovascular, and atrial Fibrillation-Related hospitalizations: focus on antiarrhythmic drugs. JACC Adv. 2024;3(8):101117.","journal-title":"JACC Adv"},{"key":"6733_CR17","doi-asserted-by":"crossref","unstructured":"Yamashita T, Akao M, Atarashi H, Ikeda T, Koretsune Y, Okumura K et al. Causes of death in elderly patients with Non-Valvular atrial Fibrillation - Results from the ANAFIE registry. Circ J. 2023;87(7):957\u2013963.","DOI":"10.1253\/circj.CJ-22-0614"},{"issue":"11","key":"6733_CR18","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.032226","volume":"13","author":"TC Frederiksen","year":"2024","unstructured":"Frederiksen TC, Benjamin EJ, Trinquart L, Lin H, Dahm CC, Christiansen MK, et al. Bidirectional association between atrial fibrillation and myocardial infarction, and relation to mortality in the Framingham heart study. J Am Heart Assoc. 2024;13(11):e032226.","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"6733_CR19","first-page":"119","volume":"37","author":"AA Karnik","year":"2019","unstructured":"Karnik AA, Gopal DM, Ko D, Benjamin EJ, Helm RH. Epidemiology of atrial fibrillation and heart failure: a growing and important problem. Cardiol Clin. 2019;37(2):119\u201329.","journal-title":"Cardiol Clin"},{"key":"6733_CR20","doi-asserted-by":"crossref","unstructured":"Cilla F, Sabione I, D\u2019Amelio P. Risk factors for early hospital readmission in geriatric patients: A systematic review. Int J Environ Res Public Health. 2023;20(3)20(3):1674.","DOI":"10.3390\/ijerph20031674"},{"key":"6733_CR21","volume":"27","author":"H Ehrlinder","year":"2020","unstructured":"Ehrlinder H, Orsini N, Modig K, Hofman-Bang C, Wall\u00e9n H, Gigante B. Clinical characteristics and antithrombotic prescription in elderly hospitalized atrial fibrillation patients: a cross-sectional analysis of a Swedish single-center clinical cohort. Int J Cardiol Heart Vasc. 2020;27:100505.","journal-title":"Int J Cardiol Heart Vasc"},{"issue":"5","key":"6733_CR22","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstrom-Lundqvist C, et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European association for Cardio-Thoracic surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European society of cardiology (ESC) developed with the special contribution of the European heart rhythm association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373\u2013498.","journal-title":"Eur Heart J"},{"key":"6733_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-11-450","volume":"11","author":"JF Ludvigsson","year":"2011","unstructured":"Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim JL, Reuterwall C, et al. External review and validation of the Swedish National inpatient register. BMC Public Health. 2011;11:450.","journal-title":"BMC Public Health"},{"issue":"9","key":"6733_CR24","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s10654-017-0316-1","volume":"32","author":"HL Brooke","year":"2017","unstructured":"Brooke HL, Talb\u00e4ck M, H\u00f6rnblad J, Johansson LA, Ludvigsson JF, Druid H, et al. The Swedish cause of death register. Eur J Epidemiol. 2017;32(9):765\u201373.","journal-title":"Eur J Epidemiol"},{"key":"6733_CR25","unstructured":"Therneau TC, Atkinson C. E.;. Using time dependent covariates and time dependent coefficients in the Cox model. 2024."},{"issue":"2","key":"6733_CR26","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ahj.2004.08.005","volume":"149","author":"KF Adams Jr.","year":"2005","unstructured":"Adams KF Jr., Fonarow GC, Emerman CL, LeJemtel TH, Costanzo MR, Abraham WT, et al. Characteristics and outcomes of patients hospitalized for heart failure in the united states: rationale, design, and preliminary observations from the first 100,000 cases in the acute decompensated heart failure national registry (ADHERE). Am Heart J. 2005;149(2):209\u201316.","journal-title":"Am Heart J"},{"issue":"10","key":"6733_CR27","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1002\/ejhf.890","volume":"19","author":"O Chioncel","year":"2017","unstructured":"Chioncel O, Mebazaa A, Harjola VP, Coats AJ, Piepoli MF, Crespo-Leiro MG, et al. Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC heart failure Long-Term registry. Eur J Heart Fail. 2017;19(10):1242\u201354.","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"6733_CR28","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1161\/CIRCULATIONAHA.122.057444","volume":"146","author":"YNV Reddy","year":"2022","unstructured":"Reddy YNV, Borlaug BA, Gersh BJ. Management of atrial fibrillation across the spectrum of heart failure with preserved and reduced ejection fraction. Circulation. 2022;146(4):339\u201357.","journal-title":"Circulation"},{"issue":"1","key":"6733_CR29","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jchf.2018.09.008","volume":"7","author":"RB Patel","year":"2019","unstructured":"Patel RB, Vaduganathan M, Rikhi A, Chakraborty H, Greene SJ, Hernandez AF, et al. History of atrial fibrillation and trajectory of decongestion in acute heart failure. JACC Heart Fail. 2019;7(1):47\u201355.","journal-title":"JACC Heart Fail"},{"issue":"10206","key":"6733_CR30","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/S0140-6736(19)31786-6","volume":"394","author":"EO Hoogendijk","year":"2019","unstructured":"Hoogendijk EO, Afilalo J, Ensrud KE, Kowal P, Onder G, Fried LP. Frailty: implications for clinical practice and public health. Lancet. 2019;394(10206):1365\u201375.","journal-title":"Lancet"},{"issue":"6\u20137","key":"6733_CR31","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.acvd.2016.02.002","volume":"109","author":"A Teixeira","year":"2016","unstructured":"Teixeira A, Arrigo M, Tolppanen H, Gayat E, Laribi S, Metra M, et al. Management of acute heart failure in elderly patients. Arch Cardiovasc Dis. 2016;109(6\u20137):422\u201330.","journal-title":"Arch Cardiovasc Dis"},{"issue":"9921","key":"6733_CR32","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","volume":"383","author":"CT Ruff","year":"2014","unstructured":"Ruff CT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz MD, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet. 2014;383(9921):955\u201362.","journal-title":"Lancet"},{"issue":"15","key":"6733_CR33","doi-asserted-by":"publisher","first-page":"e026410","DOI":"10.1161\/JAHA.122.026410","volume":"11","author":"WY Ding","year":"2022","unstructured":"Ding WY, Lane DA, Gupta D, Huisman MV, Lip GYH. Incidence and risk factors for residual adverse events despite anticoagulation in atrial fibrillation: results from phase II\/III of the GLORIA-AF registry. J Am Heart Assoc. 2022;11(15):e026410.","journal-title":"J Am Heart Assoc"},{"issue":"7","key":"6733_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/rth2.12823","volume":"6","author":"H Ehrlinder","year":"2022","unstructured":"Ehrlinder H, Orsini N, Modig K, Wallen H, Gigante B. Antithrombotic treatment switching in elderly patients with atrial fibrillation and the risk of thromboembolism, bleeding, and cardiac death. Res Pract Thromb Haemost. 2022;6(7):e12823.","journal-title":"Res Pract Thromb Haemost"},{"issue":"8","key":"6733_CR35","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1001\/jama.2011.1206","volume":"306","author":"CM Bell","year":"2011","unstructured":"Bell CM, Brener SS, Gunraj N, Huo C, Bierman AS, Scales DC, et al. Association of ICU or hospital admission with unintentional discontinuation of medications for chronic diseases. JAMA. 2011;306(8):840\u20137.","journal-title":"JAMA"},{"key":"6733_CR36","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ejim.2019.05.002","volume":"65","author":"P Gallo","year":"2019","unstructured":"Gallo P, De Vincentis A, Pedone C, Nobili A, Tettamanti M, Gentilucci UV, et al. Drug-drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients. Eur J Intern Med. 2019;65:51\u20137.","journal-title":"Eur J Intern Med"},{"issue":"15","key":"6733_CR37","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1161\/CIRCULATIONAHA.110.986661","volume":"123","author":"P Jabre","year":"2011","unstructured":"Jabre P, Roger VL, Murad MH, Chamberlain AM, Prokop L, Adnet F, et al. Mortality associated with atrial fibrillation in patients with myocardial infarction: a systematic review and meta-analysis. Circulation. 2011;123(15):1587\u201393.","journal-title":"Circulation"},{"issue":"14","key":"6733_CR38","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1177\/2047487317715769","volume":"24","author":"V Ruddox","year":"2017","unstructured":"Ruddox V, Sandven I, Munkhaugen J, Skattebu J, Edvardsen T, Otterstad JE. Atrial fibrillation and the risk for myocardial infarction, all-cause mortality and heart failure: a systematic review and meta-analysis. Eur J Prev Cardiol. 2017;24(14):1555\u201366.","journal-title":"Eur J Prev Cardiol"},{"issue":"2","key":"6733_CR39","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.tcm.2022.09.006","volume":"34","author":"M Mekhael","year":"2024","unstructured":"Mekhael M, Marrouche N, Hajjar AHE, Donnellan E. The relationship between atrial fibrillation and coronary artery disease: understanding common denominators. Trends Cardiovasc Med. 2024;34(2):91\u20138.","journal-title":"Trends Cardiovasc Med"},{"issue":"6","key":"6733_CR40","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1016\/j.jtcvs.2018.10.040","volume":"157","author":"SA Huygens","year":"2019","unstructured":"Huygens SA, Etnel JRG, Hanif M, Bekkers JA, Bogers A, Rutten-van Molken M, et al. Bioprosthetic aortic valve replacement in elderly patients: Meta-analysis and microsimulation. J Thorac Cardiovasc Surg. 2019;157(6):2189\u2013e9714.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"6","key":"6733_CR41","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1177\/15385744241253201","volume":"58","author":"RL Pessoa","year":"2024","unstructured":"Pessoa RL, Kessler VG, Becker GG, Garcia GM, Duarte Araldi PV, Aver PV. Efficacy and safety of direct oral anticoagulants for acute treatment of venous thromboembolism in older adults: a network meta-analysis of randomised controlled trials. Vasc Endovascular Surg. 2024;58(6):633\u20139.","journal-title":"Vasc Endovascular Surg"},{"issue":"3","key":"6733_CR42","first-page":"227","volume":"8","author":"R De Caterina","year":"2022","unstructured":"De Caterina R, Patti G, Westerbergh J, Horowitz J, Ezekowitz JA, Lewis BS, et al. Heterogeneity of diabetes as a risk factor for major adverse cardiovascular events in anticoagulated patients with atrial fibrillation: an analysis of the ARISTOTLE trial. Eur Heart J. 2022;8(3):227\u201335.","journal-title":"Eur Heart J"},{"issue":"9","key":"6733_CR43","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13799","volume":"52","author":"A Bhat","year":"2022","unstructured":"Bhat A, Gan GCH, Chen HHL, Nawaz S, Khanna S, Dobbins T, et al. Prognostic implications of traditional and non-traditional cardiovascular risk factor profiles in patients with non-valvular atrial fibrillation. Eur J Clin Invest. 2022;52(9):e13799.","journal-title":"Eur J Clin Invest"},{"issue":"5","key":"6733_CR44","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s11897-022-00560-3","volume":"19","author":"N Beydoun","year":"2022","unstructured":"Beydoun N, Feinstein MJ. Heart failure in chronic infectious and inflammatory conditions: mechanistic insights from clinical heterogeneity. Curr Heart Fail Rep. 2022;19(5):267\u201378.","journal-title":"Curr Heart Fail Rep"}],"container-title":["BMC Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-025-06733-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12877-025-06733-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-025-06733-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T17:02:45Z","timestamp":1765299765000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgeriatr.biomedcentral.com\/articles\/10.1186\/s12877-025-06733-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,9]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6733"],"URL":"https:\/\/doi.org\/10.1186\/s12877-025-06733-8","relation":{},"ISSN":["1471-2318"],"issn-type":[{"type":"electronic","value":"1471-2318"}],"subject":[],"published":{"date-parts":[[2025,12,9]]},"assertion":[{"value":"19 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1007"}}